{"label_logits": [-0.2634456753730774, 0.06934933364391327, -0.3550487160682678], "label_probs": [0.30235883593559265, 0.42174863815307617, 0.2758925259113312], "claim": "Naproxen relieves ailments.", "premise_source_doc_id": "Naproxen", "premise_source_doc_line_num": 0, "premise_source_doc_sentence": "Naproxen  (  brand names : Aleve , Naprosyn , and many others  )  is a nonsteroidal anti-inflammatory drug  (  NSAID  )  of the propionic acid class  (  the same class as ibuprofen  )  that relieves pain , fever , swelling , and stiffness ."}
{"label_logits": [-0.440777987241745, -1.532339096069336, -0.1095276027917862], "label_probs": [0.3665151298046112, 0.12303619831800461, 0.510448694229126], "claim": "Naproxen relieves ailments.", "premise_source_doc_id": "Chomoqlu_Sheyda", "premise_source_doc_line_num": 0, "premise_source_doc_sentence": "Chomoqlu Sheyda  (  چمقلوشيدا , also Romanized as Chomoqlū Sheydā and Chomoqlū-ye Sheydā ; also known as Chagholū-ye Sheydā , Chāmagūlī , Chāmeh Gūl , Chamghola Sheīda , Chamgholū-ye Sheydā , Chamqolū , and Chamqolū  )  is a village in Lak Rural District , Serishabad District , Qorveh County , Kurdistan Province , Iran ."}
{"label_logits": [-0.6381091475486755, -1.4118316173553467, 0.2805805802345276], "label_probs": [0.25206077098846436, 0.11627379804849625, 0.6316654682159424], "claim": "Naproxen relieves ailments.", "premise_source_doc_id": "Naproxen-SLH-diphenhydramine", "premise_source_doc_line_num": 0, "premise_source_doc_sentence": "Naproxen/diphenhydramine  (  trade name Aleve PM  )  is a formulation of naproxen with diphenhydramine marketed by Bayer Healthcare ."}
{"label_logits": [0.7631959915161133, -1.1430599689483643, -0.7269131541252136], "label_probs": [0.7278105616569519, 0.10817874222993851, 0.164010688662529], "claim": "Naproxen relieves ailments.", "premise_source_doc_id": "Naproxen", "premise_source_doc_line_num": 4, "premise_source_doc_sentence": "Naproxen poses an intermediate risk of stomach ulcers compared with ibuprofen , which is low-risk , and indometacin , which is high-risk ."}
{"label_logits": [0.3391808867454529, -0.5112391710281372, -0.6450010538101196], "label_probs": [0.5552531480789185, 0.237223818898201, 0.20752300322055817], "claim": "Naproxen relieves ailments.", "premise_source_doc_id": "COX-inhibiting_nitric_oxide_donator", "premise_source_doc_line_num": 11, "premise_source_doc_sentence": "Several CINODs are currently being tested in clinical trials , the most advanced of which are being conducted by the French pharmaceutical company NicOx , whose flagship compound naproxcinod  (  NO-naproxen , nitronaproxen  )  is in phase III trials for the treatment of osteoarthritis ."}
